Danny R. Howard

706 total citations
15 papers, 502 citations indexed

About

Danny R. Howard is a scholar working on Surgery, Pediatrics, Perinatology and Child Health and Pharmacology. According to data from OpenAlex, Danny R. Howard has authored 15 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 4 papers in Pediatrics, Perinatology and Child Health and 4 papers in Pharmacology. Recurrent topics in Danny R. Howard's work include Nausea and vomiting management (4 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Anesthesia and Sedative Agents (3 papers). Danny R. Howard is often cited by papers focused on Nausea and vomiting management (4 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Anesthesia and Sedative Agents (3 papers). Danny R. Howard collaborates with scholars based in United States, Canada and Switzerland. Danny R. Howard's co-authors include Sandip Kumar Roy, Srikumar Sahasranaman, Peter L. Bonate, Matthew A. Howard, Steven H. Neau, Ellen Dempsey, Neal R. Cutler, John J. Sramek, Jean‐Marie Leclerc and Randall D. Seifert and has published in prestigious journals such as International Journal of Pharmaceutics, Clinical Pharmacology & Therapeutics and European Journal of Clinical Pharmacology.

In The Last Decade

Danny R. Howard

15 papers receiving 482 citations

Peers

Danny R. Howard

PHEOH

PPCH

GENET

PHARM

Ryan S. Funk United States

Remco L.A. de Vrueh Netherlands

I Bekersky United States

Dulal C. Chatterji United States

Tong Zhu United States

Ganesh S. Moorthy United States

Kana Matsumoto Japan

Amitabh Prakash New Zealand

D. Farquhar United States

Martin Czejka Austria

Ryan S. Funk United States

Danny R. Howard

286 ×2.4

77 ×0.7

PHEOH

107 ×1.7

PPCH

37 ×0.6

GENET

82 ×1.5

PHARM

Citations per year, relative to Danny R. Howard Danny R. Howard (= 1×) peers Ryan S. Funk

Countries citing papers authored by Danny R. Howard

Since Specialization

Citations

This map shows the geographic impact of Danny R. Howard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danny R. Howard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danny R. Howard more than expected).

Fields of papers citing papers by Danny R. Howard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danny R. Howard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danny R. Howard. The network helps show where Danny R. Howard may publish in the future.

Co-authorship network of co-authors of Danny R. Howard

This figure shows the co-authorship network connecting the top 25 collaborators of Danny R. Howard. A scholar is included among the top collaborators of Danny R. Howard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danny R. Howard. Danny R. Howard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Howard, Danny R. & Peter L. Bonate. (2016). Pharmacokinetics in Drug Development. DIAL (Catholic University of Leuven). 3 indexed citations

Bonate, Peter L. & Danny R. Howard. (2011). Pharmacokinetics in Drug Development. Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)). 40 indexed citations

Sahasranaman, Srikumar, Danny R. Howard, & Sandip Kumar Roy. (2008). Clinical pharmacology and pharmacogenetics of thiopurines. European Journal of Clinical Pharmacology. 64(8). 753–767. 290 indexed citations

Howard, Danny R., et al.. (2005). Single-dose and steady-state bioequivalence of fexofenadine and pseudoephedrine combination tablets compared with individual formulations in healthy adults. Current Medical Research and Opinion. 21(5). 769–775. 7 indexed citations

Bonate, Peter L. & Danny R. Howard. (2000). Critique of Prospective Allometric Scaling: Does the Emperor Have Clothes?. The Journal of Clinical Pharmacology. 40(4). 335–340. 30 indexed citations

Bonate, Peter L. & Danny R. Howard. (2000). Rebuttal to Mahmood. The Journal of Clinical Pharmacology. 40(6). 675–676. 3 indexed citations

Bonate, Peter L. & Danny R. Howard. (2000). Rebuttal to Mahmood. The Journal of Clinical Pharmacology. 40(4). 345–346. 3 indexed citations

Bonate, Peter L. & Danny R. Howard. (2000). Prospective Allometric Scaling: Does the Emperor Have Clothes?. The Journal of Clinical Pharmacology. 40(6). 665–670. 24 indexed citations

Coppes, Max J., Rochelle Yanofsky, Sheila Pritchard, et al.. (1999). Safety, Tolerability, Antiemetic Efficacy, and Pharmacokinetics of Oral Dolasetron Mesylate in Pediatric Cancer Patients Receiving Moderately to Highly Emetogenic Chemotherapy. Journal of Pediatric Hematology/Oncology. 21(4). 274–283. 12 indexed citations

10.

Coppes, Max J., Kung Wong Lau, Lewis C. Ingram, et al.. (1999). Open-label comparison of the antiemetic efficacy of single intravenous doses of dolasetron mesylate in pediatric cancer patients receiving moderately to highly emetogenic chemotherapy. Medical and Pediatric Oncology. 33(2). 99–105. 10 indexed citations

11.

Neau, Steven H., et al.. (1999). The effect of the aqueous solubility of xanthine derivatives on the release mechanism from ethylcellulose matrix tablets. International Journal of Pharmaceutics. 179(1). 97–105. 47 indexed citations

12.

Coppes, Max J., Kung Wong Lau, Lewis C. Ingram, et al.. (1999). Open‐label comparison of the antiemetic efficacy of single intravenous doses of dolasetron mesylate in pediatric cancer patients receiving moderately to highly emetogenic chemotherapy. Medical and Pediatric Oncology. 33(2). 99–105. 1 indexed citations

13.

Lerman, Jerrold, Nancy Sikich, Robert M. Gow, et al.. (1996). Pharmacokinetics of the active metabolite (MDL 74,156) of dolasetron mesylate after oral or intravenous administration to anesthetized children*. Clinical Pharmacology & Therapeutics. 60(5). 485–492. 10 indexed citations

14.

Cutler, Neal R., Randall D. Seifert, John J. Sramek, et al.. (1995). Acetylcholinesterase inhibition by zifrosilone: Pharmacokinetics and pharmacodynamics*. Clinical Pharmacology & Therapeutics. 58(1). 54–61. 21 indexed citations

15.

Neau, Steven H. & Danny R. Howard. (1991). Partial molal volumes of n-alkyl p-aminobenzoates in nonpolar solvents. International Journal of Pharmaceutics. 77(2-3). 239–246. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact